NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Why Indivior (INDV) Is Up 7.1% After London Delisting for Sole Nasdaq Listing and What's Next

On July 25, 2025, Indivior completed its delisting from the London Stock Exchange, maintaining a sole primary listing on the Nasdaq Stock Market. This shift puts a sharper spotlight on the company's US market focus and may streamline how global investors access Indivior shares. We'll explore how the London delisting sharpens Indivior's profile for US-based investors and influences its investment narrative going forward. This technology could replace computers: discover the 26 stocks are...
NasdaqGS:HON
NasdaqGS:HONIndustrials

Honeywell International (HON) Declares US$1.13 Quarterly Dividend Payment

Honeywell International (HON) recently announced a quarterly dividend affirmation, maintaining investor confidence with a payment of $1.13 per share. Despite market conditions with a broader 1% climb last week and 17% over the last year, Honeywell's 13% price increase over the last quarter stands out. Notably, the company's strong Q2 earnings, raised sales forecast, and strategic alternatives for business restructuring likely strengthened its market position. Executives such as Jim Masso...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Gains CHMP Approval for Donanemab in Alzheimer's Treatment

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a crucial therapeutic area. During the same period, LLY registered a 5% share price increase, notably outpacing the broader market's 1% rise over the past week. This uptrend in LLY's stock could be attributed to investors' optimism about donanemab's potential impact. Additionally, the company's...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing authorization of their COVID-19 vaccine, which likely contributed to Pfizer's share price increase of 8% in the last quarter. The company's advancements in COVID-19 vaccine development, alongside other product-related announcements like the XTANDI and BRAFTOVI trial results, added weight to this upward movement. Despite legal challenges and declining earnings, Pfizer's...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix (NFLX) Premieres K-Content Thriller 'Trigger' In Global Release

During the last quarter, "Trigger," a series by K Wave Media and a Netflix worldwide release, highlighted the company's expanding global content strategy. Alongside an increase in Q2 sales and net income, Netflix (NFLX) announced positive earnings and revised its full-year earnings guidance, indicating robust operational growth. The company's strategic alliances, such as its collaboration with Telefilms Ltd. and opening Netflix House locations, likely reinforced investor confidence. While...
NYSE:EME
NYSE:EMEConstruction

EMCOR Group (EME) Sees EPS Surge as Net Income Climbs to US$241 Million

EMCOR Group (EME) recently announced a regular quarterly cash dividend of $0.25 per common share, to be paid on July 31, 2025. This steady dividend approach aligns with the company's robust quarterly performance, which saw net income rise to $241 million and EPS increase substantially year-over-year. Additionally, the ongoing share buyback program has strengthened shareholder returns. Despite the broader market's moderate growth of 1.4% over the past week and 17% over the past year, EMCOR's...